| |
Our portfolio
Our
portfolio | Investment Guidelines |
Valuation Guidelines
|
Performance of ProgressNow!
|
as
per 05.03.2010
|
| Share price (SWX Swiss
Exchange) |
CHF 8.32 |
| Performance since 1.1.2010 |
-10.5% |
| Net Asset Value (preliminary unaudited
figure) |
CHF 19.50 |
|
Portfolio
|
as per 05.03.2010 |
| Company |
Amount |
Historical
price |
Current
valuation
per share |
+ / - |
Fair value
(in CHF) |
% of
portfolio |
| Cadent Holdings, Inc | 336'372 | USD 5.92 | USD 4.29 | -27.5% | 1'551'482.09 | 12.4% | | Cadent warrants | 637 | USD 0.00 | USD 3.97 | 0.0% | 2'719.11 | 0.0% | | Enablearning, Inc | 1'452'905 | USD 0.87 | USD 0.00 | -100.0% | 0.00 | 0.0% | | Hansen Medical, Inc | 63'011 | USD 5.60 | USD 2.26 | -59.6% | 152'985.54 | 1.2% | | Oceanlinx Ltd | 348'179 | AUD 2.00 | AUD 0.35 | -82.5% | 118'803.90 | 1.0% | | Velico Medical, Inc | 9'906'585 | USD 0.92 | USD 1.00 | 8.8% | 10'642'644.27 | 85.4% |
|
Total (in CHF)
|
12'468'634.90 |
100.0% |
Exchange rate in CHF | | USD | 1.0743 | | AUD | 0.9749 | | GBP | 1.6255 |
|
|